Advertisement

Canada approves 1st HIV self-test to help reduce screening barriers

Click to play video: 'Canada approves first made in B.C. HIV self-test kit'
Canada approves first made in B.C. HIV self-test kit
Health Canada has approved the first HIV self-test kit in Canada, made by a company in Richmond – Nov 3, 2020

Federal regulators have approved the first HIV self-test in Canada in a long-awaited move that experts have called critical to reaching people who don’t know they have the virus.

Health Canada granted a medical device licence on Monday to a one-minute, finger-prick blood test manufactured by Richmond, B.C.-based bioLytical Laboratories.

READ MORE: Only half of children with HIV are getting treatment due to coronavirus, UN report says

Canada follows dozens of other countries in greenlighting the technology, which has been endorsed by the World Health Organization as a tool to reduce the number of people with undiagnosed HIV.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

The principal investigator of a study that was submitted to regulators as part of their review says the approval of HIV self-testing could “open incredible doors” to increasing access to life-extending treatments and preventing the spread of infection in Canada.

Story continues below advertisement

Dr. Sean Rourke, a scientist with the Centre for Urban Health Solutions at St. Michael’s Hospital in Toronto, says he’s working with community organizations across the country to launch a telehealth program in January that will distribute 60,000 self-tests and connect people with care.

Click to play video: 'Pioneering B.C. HIV/AIDS researcher gets ‘stamp’ of approval'
Pioneering B.C. HIV/AIDS researcher gets ‘stamp’ of approval

Rourke says the need for self-testing has become even more important as a recent survey of roughly 300 front-line providers suggests the COVID-19 crisis has cut access to clinical HIV testing services nearly in half.

Sponsored content

AdChoices